when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

calendar

1 catalysts · 1 phase 2 completion

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

sort

soonest latest type sponsor alpha

matching 'Keytruda'×TA: oncology×clear all

search

type

phase 2 completion1

therapy area

Infectious Disease1
Oncology1

Week of Apr 27, 2026

1

›Apr 30, 2026phase 2 completion

130d ago

Merck & Co Inc — pembrolizumab (Phase II Trial Completion)pembrolizumab

Therapy area: Oncology. Indication: Glioblastoma Multiforme (GBM), Gliosarcoma

full page →pembrolizumab →source: globaldata

$MRK150.33-1.32%